A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan
| Autor: | Haranaka, Miwa, Young Song, Joon, Huang, Kuo-Chin, de Solom, Richard, Yamaji, Masako, McElwee, Kathleen, Kline, Mary, Aizawa, Masakazu, Peng, Yahong, Scully, Ingrid, Kogawara, Osamu, Gruber, William C., Scott, Daniel A., Watson, Wendy |
|---|---|
| Zdroj: | In Vaccine 15 February 2024 42(5):1071-1077 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect